Skip to main content

Congress discusses 'strategic opportunity' for US vaccines in MidEast

The House Foreign Affairs Committee's hearing Wednesday focused in part on the reputation of American COVID-19 vaccines in the Middle East versus Russian and Chinese ones.

people line up for Pfizer vaccine in Ankara
People line up to be vaccinated with the Pfizer vaccine against COVID-19 at the Ankara City Hospital, in Ankara, Turkey, on June 7, 2021. — ADEM ALTAN/AFP via Getty Images

Members of Congress discussed the potential for US coronavirus vaccines to be vehicles for soft power in the Middle East on Wednesday. 

Democratic Rep. Tom Malinowski of New Jersey referenced reports that the United Arab Emirates and Bahrain are offering booster shots of the US-made Pfizer vaccine to people who received China’s Sinopharm vaccine due to concerns about Sinopharm’s effectiveness.

Related Topics

Subscribe for unlimited access

All news, events, memos, reports, and analysis, and access all 10 of our newsletters. Learn more

$14 monthly or $100 annually ($8.33/month)
OR

Continue reading this article for free

All news, events, memos, reports, and analysis, and access all 10 of our newsletters. Learn more.

By signing up, you agree to Al-Monitor’s Terms and Conditions and Privacy Policy. Already have an account? Log in